BPC-157 vs MK-677 for recovery
Short answer: For recovery, users rate them about the same: 96% report improvement with BPC-157 (494 reports) and 99% with MK-677 (106 reports).
BPC-157 has 0 meta-analyses and 0 randomized trials on PubMed; MK-677 has 0 and 15.
Based on 1,613 reports about BPC-157 and 978 about MK-677. Not medical advice.
| BPC-157 Peptide | MK-677 Substance | |
|---|---|---|
| Users say it helped | 54%helped919 reports · high confidence | 39%helped479 reports · high confidence |
| Verdict | Mixed | Mixed |
| Research | DResearch: None | BResearch: Moderate |
| Meta-analyses / RCTs | 0 / 0 | 0 / 15 |
| Mainly used for | ||
| Recovery % reporting improvement | 96% (494) | 99% (106) |
| Pain & inflammation % reporting improvement | 86% (485) | 68% (22) |
| Sleep % reporting improvement | 80% (76) | 79% (170) |
| Appetite % reporting improvement | 64% (11) | 66% (228) |
| Mood % reporting improvement | 65% (128) | 52% (21) |
| Common side effects | fatigue, anhedonia, anxiety, headache | water retention, fatigue, stomach issues, hunger |
| Typical dose reported | Not listed | 12.5 mg / before dinner |
BPC-157Full BPC-157 profile →
What a user said
“after 2+ years of nothing working, this is the 1st thing to reverse significant muscle damage ... 40% increase in my range of motion, and nearly the same in muscle strength.”
MK-677Full MK-677 profile →
What a user said
“From my own experience (also have suffered from poor sleep), i experienced a noticeable increase in sleep quality even with a low dose.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate